FIELD: pharmacology.
SUBSTANCE: invention relates to a drug having an anti-inflammatory activity and comprising N-(2-hydroxyethyl)-3β-hydroxyurea-12-en-28-amide of formula
as an active ingredient.
EFFECT: a new effective drug with an anti-inflammatory activity is obtained.
2 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| N-[3-OXOLUP-20(29)-ENE-28-OIL]-2,2,6,6-TETRAMETHYLPIPERIDINE-4-YLAMINE WITH CYTOTOXIC ACTIVITY IN RESPECT OF HUMAN TUMOUR CELLS | 2017 |
|
RU2641900C1 |
| N,N'((ALKANDIYL)BIS[LABDA-7(9),13,14-TRIENE-4-CARBOXAMIDES] WITH ANTITUMOUR ACTIVITY | 2017 |
|
RU2654201C1 |
| N-ETHYLPIPERAZYLAMIDE OF BETULINIC ACID AS TRITERPENIC ANTITUMOUR AGENT | 2010 |
|
RU2445317C1 |
| PHOSPHONIUM SALTS BASED ON BETULINIC ACID GLYCOSIDES WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2803739C1 |
| (17S)-N-BENZYL-5-((3Β-ACETOXY-28-NOR-URS-12-ENE)-17-YL)-1,3,4-OXADIAZOL-2-AMINE, HAVING SELECTIVE CELL CYTOTOXICITY BREAST CANCER MCF-7 | 2019 |
|
RU2708400C1 |
| HYDROGENATED BETULONIC ACID AND AMIDES THEREOF AS TRITERPENE ANTI-TUMOUR AGENTS | 2010 |
|
RU2448115C1 |
| USNIC ACID DERIVATIVES AS ANTI-TUMOUR AGENTS | 2013 |
|
RU2536873C1 |
| ((3Β-ACETOXY-URS-12-EN-28-OYL-OXYACETOXY)METHYL)-1H-1,2,3-TRIAZOL-1-YL)METHYL)-4-METHYL-1,2,5-OXADIAZOL-2-OXIDE, HAVING SELECTIVE ANTICANCER ACTIVITY AGAINST MCF-7 BREAST CANCER CELLS | 2020 |
|
RU2739559C1 |
| HYBRID DERIVATIVES OF URSOLIC ACID AND GALLIC ACID COMPRISING 1,2,3-TRIAZOLE LINKERS WITH ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY | 2022 |
|
RU2802957C1 |
| LABDANE-TYPE 6-HYDROXYNAPHTHOQUINONES, HAVING CYTOTOXIC ACTIVITY ON HUMAN TUMOUR CELLS | 2012 |
|
RU2479582C1 |
